Siru Mäkelä

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 2

Top Topics

Ejection Fraction

Patient Reported Outcomes

Multiple Sclerosis

Top Venues

Cancer immunology, immunotherapy : CII

Acta oncologica (Stockholm, Sweden)

This page only lists publications with an associated author ORCID identifier.

Publications

Siru Mäkelä, Laura Kohtamäki, Marjut Laukka, Susanna M Juteau, Micaela M Hernberg
Limited-duration anti-PD-1 therapy for patients with metastatic melanoma. Acta oncologica (Stockholm, Sweden) 59 (4) (2020)
Henna Kasanen, Micaela M Hernberg, Siru Mäkelä, Oscar Brück, Susanna Juteau, Laura Kohtamäki, Mette Ilander, Mohamed El Missiry, Anna Kreutzman
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients. Cancer immunology, immunotherapy : CII 69 (5) (2020)